IceCure Medical Reports Record Sales of ProSense® and Strengthens Market Position IceCure Medical reports record-breaking 2025 sales of ProSense®, following FDA approval for treating low-risk breast cancer, with strong market demand in the U.S.

IceCure Medical Reports Record Sales of ProSense® and Strengthens Market Position #Israel #Caesarea #IceCure_Medical #ProSense® #Eyal_Shamir